<DOC>
	<DOCNO>NCT00062673</DOCNO>
	<brief_summary>A study safety efficacy duloxetine elderly patient ( great 65 year old ) major depressive disorder</brief_summary>
	<brief_title>Study Duloxetine Elderly Patients With Major Depressive Disorder</brief_title>
	<detailed_description>Duloxetine 60 mg QD placebo variable-duration , placebo lead-in period 9 week acute treatment phase</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>You must able visit doctor 's office clinic visit , test , procedure . You must diagnose major depression , least one episode past . You current previous major psychiatric disorder depression , bipolar disorder , schizophrenia , psychotic disorder . You take drug within last 30 day approve use governmental authority .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>